India’s accelerating push toward bio-energy and the rapid expansion of its nutrition and wellness market are fueling demand for enzymes and microbial solutions, according to Danish bio-solutions company Novonesis. The company, formed in 2024 through the merger of Novozymes and Chr. Hansen, has been witnessing double-digit growth in its India business, driven by industries ranging from bio-fuel manufacturing to dietary supplements and bio-fertilizers.
India’s Bio-Energy Push Drives Enzyme Demand
“Bio-ethanol and bio-fuels are very, very big topic and Novonesis has been a big part in this conversion process and bringing in this technology along with other engineering partners,” said Krishna Mohan Puvvada, Regional President, Middle East, India and Africa, Novonesis. While ethanol remains the most visible opportunity, Novonesis sees the broader bio-energy segment—including biogas, biodiesel, and other renewable fuels—as an under-penetrated market with significant room for expansion in India. Enzymes play a critical role in improving conversion efficiency, enhancing yields, and reducing production costs, making them increasingly relevant as India scales up its biofuel ambitions, Puvvada added.
Novonesis Expands Indian Operations
Novonesis manufactures juice enzymes, probiotics, and vitamin K27 at its facilities in Patalganga and Wada, exporting them to global markets. The company has about a tenth of its global workforce, including R&D staff, located in India, Puvvada said. So far, Novonesis has invested around Rs 4,000 crore in Indian operations and signed a Memorandum of Understanding with Maharashtra earlier this year to invest an additional Rs 2,500–3,000 crore.
| Investment Details | Amount (Rs crore) |
|---|---|
| Existing investment in India | ~4,000 |
| New MoU with Maharashtra | 2,500–3,000 |
Beyond Energy: Nutrition, Animal Feed, and Bio-Fertilizers
Beyond energy, Novonesis is witnessing demand for its bio-solutions from segments such as food and health, animal nutrition, and bio-fertilizers, among others. The probiotics space is “dramatically expanding as the country becomes a lot more wealthy and a lot more well-informed,” Puvvada said. Consumers are increasingly adopting preventive health practices, boosting demand for probiotics, dietary supplements, and nutrition products. The company also sees significant opportunities for bio-solutions in early-life nutrition (infant formula), dairy processing, bread making, cheese production, starch processing, plant-based foods, and food additives.
Implications for Commodity Markets
While the source does not detail specific commodity prices, the ramp-up in enzyme demand signals growing industrial activity in India’s bio-energy and agri-processing sectors. Increased adoption of enzymes in bio-fuel production implies higher conversion efficiency for feedstocks such as sugarcane, corn, and waste oils—potentially affecting demand balances for these commodities. For traders and analysts, Novonesis’ reported double-digit growth in India underscores structural demand shifts that could tighten supply chains for agricultural raw materials used in bio-refining. The expansion also highlights India’s rising role as a hub for bio-manufacturing, with local production of enzymes reducing import reliance and creating new trade flows for intermediate inputs like microbial cultures and fermentation substrates.
Sources:
